Exam (elaborations) NURS ,2023/WK10 Assign NURS 6050

How was the success of the program or policy measured? According to CMS, (n.d), data is collected for analysis to determine the success of the Medicare program through interview with medical staff, focus group with caregiver staff and focus group with patients; family members, patient satisfaction surveys, financial analysis, evaluation from medical team, number of referrals, and staff turnover rate. However, Medicare part D was evaluated through patient satisfaction survey and financial analysis of the program (Medicare Access for Patients Rx (MAPR), 2018). How many people were reached by the program or policy selected? How much of an impact was realized with the program or policy selected? Since the inception of part D program in 2006 to 2018 the enrollment has almost replicated statically from 22.5 million making a total of 52% share of Medicare beneficiaries in 2006 to over 44 million of about 74 % share in 2018 with the majority part beneficiaries enroll in PDP plans than MA-PD plans (MAPR, 2018). According to MAPR, (2018), studies conducted on the impact of Prescription Drug Access on Health Outcomes in 2011 resulted to improved health for the older adults that gave rise to decreased medical services, increased medication compliance with a reduced probability of the newly enrolled beneficiaries to develop elevated blood pressure in 2015 research, evidence in 2016 research revealed that approximately 200,000 Medicare beneficiaries experience expanded livelihood to a minimum of one year longer, and 2018 study indicated that part D beneficiaries survived from myeloma significantly more than other patients with different health coverage plan. In addition to the above impact of part D, due to the intended purpose of which Part D has served by granting improved access to prescription drug, it also enhanced non-drug medical savings to Medicare part A and B and according to the Congressional Budget Office, any 1% increase in the amount of prescription drug filed by part D beneficiaries would result to a decrease in Medicare’s spending on medical services to about one-fifth of 1% (MAPR, 2018).